Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bayer Aktienges ADR (BAYRY)

Bayer Aktienges ADR (BAYRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 29,616,182
  • Shares Outstanding, K 3,929,700
  • Annual Sales, $ 51,558 M
  • Annual Income, $ -3,183 M
  • 60-Month Beta 1.11
  • Price/Sales 0.58
  • Price/Cash Flow 1.95
  • Price/Book 0.72
Trade BAYRY with:
  • Price/Earnings ttm 4.40
  • Earnings Per Share ttm 1.70
  • Most Recent Earnings $0.77 on 05/14/24
  • Next Earnings Date 05/16/24
  • Annual Dividend & Yield 0.02 (0.29%)
  • Most Recent Dividend 0.022 on 04/29/24
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.25
  • Number of Estimates 1
  • High Estimate 0.25
  • Low Estimate 0.25
  • Prior Year 0.33
  • Growth Rate Est. (year over year) -24.24%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.1200 +5.85%
on 05/01/24
8.0800 -6.73%
on 05/14/24
+0.2765 (+3.81%)
since 04/24/24
3-Month
6.9600 +8.28%
on 04/19/24
8.0800 -6.73%
on 05/14/24
-0.2235 (-2.88%)
since 02/23/24
52-Week
6.9600 +8.28%
on 04/19/24
14.7000 -48.73%
on 07/31/23
-6.9535 (-47.99%)
since 05/24/23

Most Recent Stories

More News
3 Best Agriculture ETFs to Buy for 2024

Agriculture-based exchange-traded funds (ETFs) can provide investors with portfolio diversification and a low-cost way to create a passive income stream.

DBA : 24.67 (+0.16%)
MOO : 72.68 (-0.22%)
DE : 374.96 (-1.13%)
ZTS : 170.07 (-0.49%)
BAYRY : 7.5365 (+0.76%)
NTR : 58.86 (-0.59%)
CTVA : 55.51 (-0.11%)
VEGI : 37.09 (-0.05%)
ADM : 60.49 (-0.38%)
LW : 89.21 (+1.68%)
Why Bristol Myers Squibb Stock Is Fading Today

A high-profile clinical failure by a rival is weighing on the drugmaker's shares today.

BAYRY : 7.5365 (+0.76%)
BMY : 41.24 (-0.72%)
Could This Biosimilar Drug Be Novartis' Next Blockbuster?

Novartis expects to submit regulatory applications for its biosimilar soon.

BAYRY : 7.5365 (+0.76%)
AMD : 166.36 (+3.70%)
NVS : 100.53 (-0.57%)
REGN : 985.02 (+0.45%)
2 No-Brainer Stocks to Buy Right Now for Less than $30

Two big companies that are worth investing in have low share prices but big dividends.

BAYRY : 7.5365 (+0.76%)
MPW : 5.04 (unch)
Regeneron (REGN) Q1 Earnings & Sales Top, Eylea Sales Decline

Regeneron (REGN) beats earnings and sales estimates in first-quarter 2023 fueled by Dupixent. However, sales of the lead drug Eylea declined yet again.

REGN : 985.02 (+0.45%)
SNY : 48.54 (-0.94%)
RHHBY : 31.6000 (-0.60%)
BAYRY : 7.5365 (+0.76%)
ROTH MKM's Agribusiness Investment Banking Group Sees Success with the Closing of Three M&A Sellside Transactions

ROTH MKM (“Roth”), www.roth.com , a relationship-driven investment bank focused on serving growth companies and their investors, is pleased to announce that their agribusiness investment banking group...

CTVA : 55.51 (-0.11%)
MBII : 0.7981 (-20.19%)
BIOX : 10.95 (+0.46%)
BAYRY : 7.5365 (+0.76%)
BG : 103.77 (+1.37%)
CVX : 157.75 (+0.52%)
Unity (UNX) Down on Disappointing Results From Wet AMD Study

Unity's (UBX) phase II ENVISION study on UBX1325 fails to meet the non-inferiority threshold compared to aflibercept through 24 weeks in the wet AMD study.

REGN : 985.02 (+0.45%)
BAYRY : 7.5365 (+0.76%)
UBX : 1.4800 (+1.37%)
Regeneron (REGN) Gets Label Extension for Cholesterol Drug

Regeneron (REGN) gets FDA approval for Evkeeza to treat children aged 5 to 11 with homozygous familial hypercholesterolemia.

REGN : 985.02 (+0.45%)
SNY : 48.54 (-0.94%)
BAYRY : 7.5365 (+0.76%)
Regeneron (REGN) Gains 9.3% in a Year: Will the Uptrend Last?

Regeneron (REGN) has had a good run in the past 12 months and the momentum should continue in 2023 on the back of growth in Dupixent, as Eylea faces challenges.

REGN : 985.02 (+0.45%)
SNY : 48.54 (-0.94%)
BAYRY : 7.5365 (+0.76%)
Bayer's (BAYRY) Q4 Earnings and Revenues Top, Outlook Weak

Bayer (BAYRY) beats on earnings and sales in the fourth quarter. However, its 2023 outlook is dismal.

REGN : 985.02 (+0.45%)
NVS : 100.53 (-0.57%)
JNJ : 146.97 (-1.82%)
BAYRY : 7.5365 (+0.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Bayer AG is a life science company with core competencies in the areas of health care and agriculture. With the company's focus completely on the Life Science businesses, a new organizational structure was introduced effective Jan 1, 2016. Bayer Group now comprise exclusively of the Life Science businesses....

See More

Key Turning Points

3rd Resistance Point 7.6890
2nd Resistance Point 7.6295
1st Resistance Point 7.5830
Last Price 7.5365
1st Support Level 7.4770
2nd Support Level 7.4175
3rd Support Level 7.3710

See More

52-Week High 14.7000
Fibonacci 61.8% 11.7433
Fibonacci 50% 10.8300
Fibonacci 38.2% 9.9167
Last Price 7.5365
52-Week Low 6.9600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar